rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
19 Pt 1
|
pubmed:dateCreated |
2005-10-5
|
pubmed:abstractText |
Patients with ovarian clear cell adenocarcinoma generally have a poor response to combination chemotherapy and have overall poorer prognosis than patients with other histologic types of ovarian cancer. Genetic changes in this group of cancer have not been thoroughly explored. Identification of these changes may provide us new therapeutic targets to treat this disease.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1078-0432
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6880-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:16203778-ATP-Binding Cassette Transporters,
pubmed-meshheading:16203778-Adenocarcinoma, Clear Cell,
pubmed-meshheading:16203778-Adult,
pubmed-meshheading:16203778-Aged,
pubmed-meshheading:16203778-Blotting, Western,
pubmed-meshheading:16203778-Cell Line,
pubmed-meshheading:16203778-Cell Line, Tumor,
pubmed-meshheading:16203778-Cytoplasm,
pubmed-meshheading:16203778-DNA,
pubmed-meshheading:16203778-DNA, Complementary,
pubmed-meshheading:16203778-Female,
pubmed-meshheading:16203778-Gene Expression Profiling,
pubmed-meshheading:16203778-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:16203778-Humans,
pubmed-meshheading:16203778-Middle Aged,
pubmed-meshheading:16203778-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:16203778-Oligonucleotides,
pubmed-meshheading:16203778-Ovarian Neoplasms,
pubmed-meshheading:16203778-Prognosis,
pubmed-meshheading:16203778-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:16203778-Transfection,
pubmed-meshheading:16203778-Treatment Outcome,
pubmed-meshheading:16203778-Tumor Markers, Biological
|
pubmed:year |
2005
|
pubmed:articleTitle |
Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analyses.
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Laboratory of Gynecologic Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|